Cover Image

FILARIASIS DISTRIBUTION AND COVERAGE OF MASS DRUG ADMINISTRATION

Background: Filariasis is still a serious health problem in Indonesia. One of the endemic areas is Demak, which implemented a mass drug administration (MDA) elimination programme in 2016. However, filariasis was still found in 2017-18. Purpose: This research aims to describe the distribution of fila...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ikha Solikha (Author), M. Sakundarno Adi (Author)
Format:	Book
Published:	Universitas Airlangga, 2019-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Coverage evaluation of mass drug administration for lymphatic filariasis in Bidar district, Karnataka, India
by: H S Ravish, et al.
Published: (2015)

Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts
by: Prakash Kurubarahalli Patel
Published: (2012)

Mass Drug Administration for Lymphatic Filariasis Elimination in Two Districts of North Karnataka: Coverage and Compliance Assessment
by: Huluvadi Shivalingaiah Anwith, et al.
Published: (2020)

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat
by: Kumar Pradeep, et al.
Published: (2008)

A Study of Coverage and Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Rewa District Of Madhya Pradesh
by: Amarnath Gupta, et al.
Published: (2014)

A Study on Coverage Evaluation, Compliance and Awareness of Mass Drug Administration for Elimination of Lymphatic Filariasis in Osmanabad District
by: Lata B Godale, et al.
Published: (2012)

Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis.
by: Philip J Budge, et al.
Published: (2016)

National mass drug administration costs for lymphatic filariasis elimination.
by: Ann S Goldman, et al.
Published: (2007)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
by: Chet Raj Ojha, et al.
Published: (2017)

Coverage And Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Endemic Areas of Sagar and Damoh Districts, Madhya Pradesh
by: Arvind Sharma, et al.
Published: (2013)

The Prevalence of Lymphatic Filariasis in Elementary School Children Living in Endemic Areas: A Baseline Survey Prior to Mass Drug Administration in Pekalongan District-Indonesia
by: Praba GINANDJAR, et al.
Published: (2018)

Impediments to compliance during filariasis mass drug administration-Observations and recommendations to accelerate filariasis elimination in India
by: Philip Raj Abraham, et al.
Published: (2024)

Evaluation Of Coverage and Compliance of Mass Drug Administration Programme 2011 For Elimination of Lymphatic Filariasis in Nalgonda District Of Andhra Pradesh, India
by: Abhay S Nirgude, et al.
Published: (2012)

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.
by: Gabriela A Willis, et al.
Published: (2020)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
by: Abdullah Alshehri, et al.
Published: (2023)

Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?
by: Maria P Rebollo, et al.
Published: (2015)

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
by: Daniel J Tisch, et al.
Published: (2011)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
by: Wilma A Stolk, et al.
Published: (2013)

Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India
by: IP Sunish, et al.
Published: (2007)

The roles of stakeholder experience and organizational learning in declining mass drug administration coverage for lymphatic filariasis in Port-au-Prince, Haiti: A case study.
by: Breanna K Wodnik, et al.
Published: (2020)

Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania
by: Adam M. Fimbo, et al.
Published: (2023)

Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration.
by: Colleen L Lau, et al.
Published: (2014)

Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
by: Reza A Niles, et al.
Published: (2021)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
by: Carmen Maroto-Camino, et al.
Published: (2019)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
by: T S Ranganath, et al.
Published: (2012)

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
by: Dung D Pam, et al.
Published: (2017)

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
by: Alison Krentel, et al.
Published: (2013)

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
by: Paul E Simonsen, et al.
Published: (2010)

The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya
by: Caroline Kusi, et al.
Published: (2020)

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
by: Gabriela A Willis, et al.
Published: (2023)

Mid -Term Assessment of Mass Drug Administration of Dec for Filariasis in Rewa and Chhindwara Districts Of Madhya Pradesh
by: Pankaj Prasad, et al.
Published: (2013)

Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021.
by: Claudia Duguay, et al.
Published: (2024)

Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
by: Subramanian Swaminathan, et al.
Published: (2012)

Long-lasting insecticidal nets are synergistic with mass drug administration for interruption of lymphatic filariasis transmission in Nigeria.
by: Abel Eigege, et al.
Published: (2013)

Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa.
by: Mark A Schmaedick, et al.
Published: (2014)

Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti.
by: Natalya Kostandova, et al.
Published: (2022)

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
by: Paul T Cantey, et al.
Published: (2010)

Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
by: Ramakrishna U Rao, et al.
Published: (2017)

The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar.
by: Benjamin F R Dickson, et al.
Published: (2018)

Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.
by: Brian K Chu, et al.
Published: (2013)